using compounded semaglutide (GLP-1) Compounded Semaglutide- Injectable and Sublingual

Growth hormone peptides (CJC-1295, ipamorelin, sermorelin) are particularly relevant for this population because endogenous GH production declines approximately 14% per decade after age 30

This can last more than 12 weeks for patients starting at the standard titration schedule of: 0.25 mg weekly for 4 weeks, 0.5 mg weekly for 4 weeks, and 1.0 mg weekly for 4 weeks

KaplanMeier analysis was used to estimate the probability of outcome at daily time intervals with censoring applied

Monitoring confirms these beneficial effects occur as expected

Its no wonder the global GLP-1 market is already worth $47.4 billionand set to grow tenfold by 2032